Космос. Здоровье. Гормоны. Разбор со специалистом по космической медицине! Шакир Бабаев.

Scientific concepts / nature phenomena mentioned

Human physiology under spaceflight (space medicine)

• Physiological “aging” effect after long missions

  • Measurements of blood/hormones/muscle/bone in returning cosmonauts are described as roughly comparable to an Earth person aged ~75–80 years (as claimed from test outcomes).

• Blood redistribution in microgravity

  • First days: blood shifts away from the lower limbs toward the pelvic region, with possible leg pain attributed to vascular “clogging”-like sensations.
  • After ~2 weeks: redistribution toward the neck/head/upper body (collarbones, shoulders, skull). The skull is described as increasing in size due to increased blood volume.
  • After ~1 month: head/neck mobility issues described as “wrestler-like” neck movement, plus eye movement/swelling.

• Erectile and reproductive system changes

  • Many returning male cosmonauts are said to develop impotence.
  • The speaker argues some cases may be reversible, due to circulatory effects, and that persistent erection states can occur during adaptation.
  • Testicles shrinking
    • begins after 2–4 weeks
    • continues for at least 6 months (often averaged to ~8 months)
    • framed as having a cumulative effect across the reproductive system.

• Cardiovascular/respiratory rhythm changes

  • Breathing amplitude and rhythm are described as potentially influencing heart rhythm (e.g., hyperventilation-like outcomes suggested).

• Body not adapted to microgravity

  • An untrained person is described as becoming disoriented because there is no intuitive “up/down” navigation in weightlessness.

---

Radiation and mitigation ideas (space pharmacology)

• Ionizing radiation exposure quantified using sieverts/millisieverts

  • Earth cosmic radiation: ~2 mSv/year (noted as location-dependent).
  • ISS: ~400 mSv/year, presented as ~200× Earth.
  • Artemis 2 (Moon mission): ~120 mSv on the way (about a month), compared against annual Earth doses.
  • Mars concept: ~500 days stay + return described as ~1200 mSv / 1.2 Sv
    • stated as potentially lethal
    • associated with increased risk of outcomes such as cancer/dementia.

• Antioxidant/radioprotective drugs and experimental substitution

  • Experiments discussed using astaxanthin in mice to reduce damage from charged alpha particles / protons / electrons.
  • Comparison/transition discussed:
    • Cetylcysteine (also mentioned with a variant spelling, “cysetylcysteine”) vs astaxanthin
    • rationale: astaxanthin framed as a stronger antioxidant, seeking a “replacement” in conservative protocols, while considering possible synergy.
  • Study design described:
    • Two mouse groups
      • Group A: cetylcysteine + astaxanthin
      • Group B: cetylcysteine only
    • Duration: 8 months total, with ~6.5 months remaining at the time discussed
    • “double-controlled” research is claimed.

• Radiation shielding engineering limitation

  • Increasing spacecraft shielding thickness is described as becoming impractical because added mass increases fuel needs, creating a problem without an “end.”

---

Circadian rhythm and melatonin (space + supplementation debate)

• Melatonin as an antioxidant and rhythm regulator

  • On ISS: ~16 sunrises/sunsets per day, described as disrupting circadian rhythm.
  • Melatonin is described as used in large doses (e.g., 6–8) taken sublingually (under the tongue).

• Criticism: long-term melatonin dependence/withdrawal

  • Speaker claims extended use can cause physiological dependence and reduce the body’s own melatonin production (“reverse compensation”).

• Counter-position on earth use

  • Melatonin described as appropriate mainly for rare scenarios:
    • acute illness with fever context (about 3–4 days)
    • short-term jetlag-like situations
  • Strong stance against chronic melatonin use for sleep problems without diagnosing the cause.

---

Mars mission constraints and operational planning

• Launch window concept (startup window) to minimize distance

  • Mars distance cited:
    • average ~200 million km
    • maximum ~400 million km
  • Launch window: ~55–60 million km.

• Trajectory time consequences

  • Missing the launch window increases travel time from ~8–9 months to ~1.5–2 years.

• Landing risks

  • Mars landing hazards described as including:
    • lack of truly flat landing zones
    • dust forcing through and causing the landing system to list/break
  • Extensive years-long study is stated as required before crewed landings.

• Surface weakness/deconditioning claim

  • Colonists after long transit are described as arriving unable to lift/move effectively, implying prolonged rehabilitation programs on Mars are not yet available.

• Caves/crevices and sensor-driven preparation

  • Discussion includes living in caves/crevices, and using sensor data to adjust future crew preparation.

---

Hormones, dopamine, lifestyle, and testosterone framing

• Testosterone and dopamine system

  • Testosterone is described as increasing sensitivity to dopamine receptors, affecting motivation/pleasure circuitry.
  • Emphasis: do not treat a single lab value (“low testosterone”) without symptoms and context.

• Trends in testosterone decline (speaker-level claim)

  • Decline across generations since the mid-20th century is discussed, including possible decreases in testosterone or free testosterone.

• Nutrition and addiction-like pathways

  • Porn, excessive simple carbohydrates/sugar, and physical inactivity are presented as main drivers of dopamine/super-stimulation and subsequent dysfunction.

• Sugar/fructose vs obesity

  • Claims sugar intake promotes obesity and hormonal disruption.
  • Fructose described as more likely to be deposited in the liver than glucose.
  • Natural fructose from fruits framed as limited by real-world intake patterns.

---

“Healthy lifestyle” supplements and evidence disputes

• Microdosing contentious evidence

  • Strong skepticism toward microdose fly agaric, “hedgehog mushroom” (product confusion suggested), and similar compounds.
  • Described as mostly placebo, referencing a 2023 quality study (as claimed).

• Supplement vs pharmacology

  • Speaker argues supplements may help, but should not replace proper medical endocrinology/pharmacological correction when needed.

---

Brain supplements and cognition (earth-based)

• Magnesium L-threonate emphasis

  • Presented as reaching the brain (“through the gap”).
  • Tolerance varies; some forms are said to cause headaches.

• Bacopa monnieri

  • Mentioned as relevant to Alzheimer’s and Parkinson’s (framed as second-line examples).
  • (Also referred to in a playful/incorrect way as “bacopamania.”)

• Omega-3 quality and oxidation risk

  • Rancid/oxidized omega oils described as losing benefit.

• Citicoline (CDP-choline) / “haline + cytidine” breakdown

  • Claimed to increase acetylcholine, support dopamine receptors in the substantia nigra, and strengthen myelin.

• Ginkgo biloba

  • Said to support microcirculation.
  • Cautions about over-slowing or blood-thinning effects are mentioned.

• Creatine forms discussion

  • Debate about differences between creatine salts (e.g., citrate/lactate vs monohydrate) and dose practicality.

---

Prostate/inflammation, abstinence, sexual triggers (men’s health physiology)

• Prostate role in erection

  • Erection is described as highly dependent on prostate health.

• Excitement without orgasm as a trigger

  • Persistent arousal without ejaculation is claimed to cause stagnation and raise inflammation risk, eventually framed as prostatitis (and possibly varicocele).

• “Abstinence” redefined

  • Not purely “no sex,” but avoidance of “idle excitations” (e.g., avoiding fantasizing or lingering on triggers).

• Porn vs masturbation argument

  • Claim: the brain does not treat porn as real sex due to missing cues (movement, smell, touch).
  • Suggested downstream effects include different oxytocin/trust dynamics and different hormonal responses.

---

Mitochondrial dysfunction and aging theory

• Mitochondrial dysfunction as an aging mechanism

  • Mentions oxidative stress/antioxidants and skepticism toward peptides marketing (including an “80% effectiveness” claim).

• Peptides skepticism

  • Some peptides may affect recovery/connective tissue, but many are framed as marketing.

---

Methodologies / study plans explicitly described

• Astaxanthin mouse study (radioprotection)

  • Animals: mice
  • Arms:
    • Arm 1: cetylcysteine + astaxanthin
    • Arm 2: cetylcysteine only
  • Timeline:
    • Total expected duration: 8 months
    • Status: ~6.5 months left mentioned (overall progress timing is ambiguous)
  • Aim: reduce radiation-induced destructive effects from charged particles.

• Mars mission operational concept (strategy)

  • Use launch windows to minimize distance/time.
  • Planned schedule includes:
    • longer daily training + experiments while en route
    • post-landing survivability via step-by-step base construction
    • continuous health sensor monitoring

---

Researchers / sources featured (named)

No external researchers or scientific papers are clearly and reliably named in the transcript. Only organizations/institutes and programs appear clearly enough to list from the subtitles (which are described as having many recognition/translation errors).

• NASA
• ESA
• Roscosmos
• SpaceX
• Roscosmos / IBP (Institute of Biomedical Problems) — IBP referenced as an institute/medical program
• Moscow Department of Education (retraining referenced)
• Gagarin Cosmonaut Training Center (Star City)
• Lyndon B. Johnson Space Center
• WHO (World Health Organization)
• Moscow State University
• Artemis 2
• ISS (International Space Station)
• VMBP (unclear acronym in subtitles; likely an administrative/medical program entity)

Note: No individual researchers are named with sufficient confidence to attribute claims to specific scientists.